The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomised phase 3 trial of enzalutamide in androgen deprivation therapy (ADT) with radiation therapy for high risk, clinically localized prostate cancer: ENZARAD (ANZUP 1303).
 
Scott Williams
No Relationships to Disclose
 
Ian D. Davis
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Exelixis (Inst); Janssen Oncology (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - International Patent Application No: PCT /US2004/032147 (NY-ESO-1) through Ludwig Institute for Cancer Research.
 
Christopher Sweeney
Stock and Other Ownership Interests - Leuchemix
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Genentech/Roche; Janssen Biotech; Pfizer; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen Biotech (Inst); Sanofi (Inst); Sotio (Inst)
Patents, Royalties, Other Intellectual Property - Leuchemix, Parthenolide, Dimethylaminoparthenolide. Exelixis: Abiraterone plus cabozantinib combination
 
Martin R. Stockler
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Medivation (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
 
Andrew James Martin
No Relationships to Disclose
 
Wendy Hague
No Relationships to Disclose
 
Xanthi Coskinas
No Relationships to Disclose
 
Sonia Yip
No Relationships to Disclose
 
Emily Tu
No Relationships to Disclose
 
Nicola Jane Lawrence
Travel, Accommodations, Expenses - Roche
 
Namrata Nayar
No Relationships to Disclose
 
Ray McDermott
No Relationships to Disclose
 
Paul Kelly
No Relationships to Disclose
 
Olwyn Deignan
Travel, Accommodations, Expenses - Astellas Pharma; Bayer
 
Simon Hughes
No Relationships to Disclose
 
Valerie Fonteyne
Consulting or Advisory Role - Ipsen (Inst)
Research Funding - Ipsen (Inst)
Travel, Accommodations, Expenses - ferring; Ipsen
 
Bertrand F. Tombal
Honoraria - Amgen; Astellas Pharma; Bayer; Ferring; Janssen; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Ferring; Janssen; Sanofi; Steba Biotech; Takeda
Speakers' Bureau - Amgen; Janssen
Research Funding - Ferring (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Bayer; Ferring; Janssen; Sanofi
 
Paul L. Nguyen
Stock and Other Ownership Interests - Volatilyx (I)
Consulting or Advisory Role - Astellas Pharma; Augmenix; Bayer; Biogen (I); Dendreon; Ferring; GenomeDx; GigaGen (I); Infinity Pharmaceuticals (I); Medivation; Nanobiotix
Research Funding - Astellas Pharma; Janssen; Nanobiotix; Wako Diagnostics (I)
Patents, Royalties, Other Intellectual Property - Wife has a patent on volatile diagnostics of infections (I)
Travel, Accommodations, Expenses - Ferring